Archive - August 2019
Priority Review awarded to Xtandi for prostate cancer
Fiasp approved for children in Europe
BeiGene gets speedy US review for lymphoma drug zanubrutinib
NICE chief executive to step down
Skyrizi bags NICE fast-track
GSK HIV combo meets main goal in Phase III study
NICE’s long-serving chief exec Sir Andrew Dillon to step down
Pfizer goes big on gene therapy with $500m facility spend